Get the Stockscreener App
1.03
13.07%
0.1191
After Hours:
1.06
0.03
+2.91%
Onconetix Inc stock is traded at $1.03, with a volume of 47.29M.
It is up +13.07% in the last 24 hours and up +60.19% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
See More
Previous Close:
$0.9109
Open:
$1.12
24h Volume:
47.29M
Relative Volume:
29.05
Market Cap:
$4.51M
Revenue:
$735.20K
Net Income/Loss:
$-9.70M
P/E Ratio:
-0.00236
EPS:
-435.729
Net Cash Flow:
$-9.80M
1W Performance:
+61.19%
1M Performance:
+60.19%
6M Performance:
-96.60%
1Y Performance:
-99.35%
1-Day Range:
$1.00
$1.42
1-Week Range:
$0.6339
$1.42
52-Week Range:
$0.5859
$209.50
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
1.03 | 4.51M | 735.20K | -9.70M | -9.80M | -435.73 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Onconetix Inc Stock (ONCO) Latest News
Why Is Onco Micro-Cap Stock Surging 50% In Premarket? - Stocktwits
Onconetix Stock Jumps As Realbotix AI Robotics Deal Accelerates - timothysykes.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Onconetix, Inc. (ONCO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Onconetix Stock Jumps As Realbotix AI Deal Draws SRX Cash - timothysykes.com
ONCO Stock Jumps As Realbotix AI Robotics Deal Draws Strategic Money - StocksToTrade
ONCO Stock Pops As Realbotix AI Robotics Deal Gains Backing - timothysykes.com
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. - marketscreener.com
SRX Global Makes Investment in Onconetix - marketscreener.com
SRX Global says adds investment in Onconetix - tipranks.com
Onconetix, Inc. (ONCO) stock price, news, quote and history - Yahoo Finance UK
SRX Global Provides Shareholders With Update on Liquidation of Two Portfolio Investments and Adds an Investment in Onconetix (Nasdaq: ONCO) - Moomoo
Onconetix Secures Bridge Financing for Realbotix Acquisition - TipRanks
Realbotix lands up-to-$5M merger bridge loan from Onconetix - app.dealroom.co
Onconetix Provides Up to $5 Million Unsecured Loan to Realbotix; $2.5 Million Funded - TradingView
Form 8K Onconetix Inc For: 14 September By Investing.com - Investing.com UK
Onconetix (NASDAQ: ONCO) must clear a cash hurdle to close its Realbotix takeover - Stock Titan
Onconetix provides $2.5M bridge financing to Realbotix By Investing.com - Investing.com Nigeria
Realbotix LLC Announces Bridge Loan from Onconetix - Investing News Network
Onconetix provides $2.5M bridge financing to Realbotix - Investing.com
$5M lifeline from Onconetix (NASDAQ: ONCO) that cancels if its Realbotix deal closes - Stock Titan
Onconetix Inc (NASDAQ: ONCO) Share Price, ONCO Stock News, ONCO Share Price & Updates - Kalkine
Could Onconetix (NASDAQ:ONCO) Face More Volatility on Nasdaq? - Kalkine Media
Onconetix Inc (ONCO) Stock Price, Quote, News & History - Benzinga
Stay updated with the stocks that are on the move in today's after-hours session. - ChartMill
Onconetix Inc Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Onconetix, Inc. SEC Filing (Sep 4, 2026) - Stock Titan
Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - Yahoo Finance
Onconetix (NASDAQ: ONCO) flags going concern as 100M-share resale filed - Stock Titan
Onconetix Inc Key Financial Ratios – Valuation, Profitability & More - Value Research
Onconetix Inc Peer Comparison – Compare with Others - Value Research
Onconetix (ONCO) Reported Quarter: Available Data Shows the Latest Reported Performance for This Review; Shares Move 0.95% Lower in Latest TradingReturn On Assets - dars.gov.et
Onconetix (ONCO) flags going concern risk as cash burn, impairments mount - Stock Titan
Onconetix, Inc. (ONCO) Debt 2025 - Stock Titan
Onconetix (NASDAQ: ONCO) resale filing covers 100M shares tied to PIPE - Stock Titan
Realbotix Q3 Results: Revenue Falls 40%, Loss Widens Amid Scaling - scanx.trade
Realbotix Plans Online-Only Robot Line With Buyer Deposits in 2026 - Stock Titan
Onconetix Inc (ONCO) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
ONCO Stock Price, Quote & Chart - ChartMill
Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series - The Manila Times
Onconetix (ONCO) outlines Realbotix all-stock acquisition and humanoid robot TV role - Stock Titan
Onconetix subsidiary appoints co-founder to board - Investing.com
Onconetix subsidiary appoints co-founder to board By Investing.com - Investing.com Nigeria
Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG - The Manila Times
ONCO Q1 2025 Earnings: Positive EPS of $0.25 Marks a Notable Bottom-Line QuarterLow Estimate Range - dars.gov.et
Onconetix Inc (ONCO) Financial Health: Profitability & Balance Sheet Analysis - tradingkey.com
Onconetix Secures Major PIPE and Equity Facility Financing - The Globe and Mail
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Onconetix (NASDAQ: ONCO) adds $750,000,000 ELOC and $30,249,600 PIPE - Stock Titan
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):